Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

Psychopharmacology

Volumn 136, Issue 2, 1998, Pages 153-161

  Li, Xi Ming ^a   Perry, Kenneth W ^a   Wong, David T ^a   Bymaster, Frank P ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Clozapine; DA and NE release; Haloperidol; In vivo microdialysis; Nucleus accumbens; Olanzapine; Prefrontal cortex; Schizophrenia; Striatum

Indexed keywords

3 O METHYLDOPAMINE; CLOZAPINE; DOPAMINE; HALOPERIDOL; NORADRENALIN; OLANZAPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOSE RESPONSE; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOPAMINE; HALOPERIDOL; MALE; MICRODIALYSIS; NEOSTRIATUM; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PIRENZEPINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031933103     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050551     Document Type: Article

References (56)

1. Abi-Dargham A, Laruelle M, Aghajanian G, Charney D, Krystal J (1996) The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatr 9:1-17
2. Ashby CR (1996) The modulation of DA neurotransmission by other neurotransmitters. CRC Press, Boca Raton, Florida
3. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S, The olanzapine HGAD study group (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:87-96
4. Berman KF, Weinberger DR (1990) The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. In: Uylings HBM et al. (eds) Progress in brain research, vol 85. Elsevier, New York, pp 521-537
5. Breier A, Buchanan RW, Waltrip RW, Listwak S, Holmes C, Goldstein DS (1994) The effect of clozapine on plasma NE: relationship to clinical efficacy. Neuropsychopharmacology 10:1-7
6. Brunello N, Masotto C, Steardo L, Markstein R, Racagni G (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213
7. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996a) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
8. 1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology 124:87-94
9. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopamine neurons. J Neurosci 8: 1607-1619
10. Coffin VL, McHuch D, Chipkin RE, Barnett A (1992) SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys. Neurochem Int 20:141S-145S
11. 2 receptors: implications for drug mechanism of action. Life Sci 39:2571-2580
12. Deutch AY (1992) The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm (Gen Sect) [Suppl] 36:61-89
13. 1A receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 33:411-421
14. 2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99: S28-S31
15. Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebram. Neurosci Lett 182:115-118
16. Fink-Jensen A, Hansen L, Hansen JB, Nielsen EB (1996) Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain: an in vivo microdialysis study. J Psychopharmacol 10:119-125
17. Fuller RW, Perry KW (1989) Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. J Pharmacol Exp Ther 248:50-56
18. Fuller RW, Snoddy HD, Perry KW (1978) Effects of prazosin on NE concentration and turnover in rat brain and heart. Arch Int Pharmacodyn Ther 231:30-40
19. Fulton B, Goa KL (1997) Olanzapine. Drugs 53:281-298
20. Goldman-Rakic P (1994) Cerebral cortical mechanisms in schizophrenia. Neuropsychopharmacology 10:22S-27S
21. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79-86
22. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous NE on extracellular DA in rat medial prefrontal cortex. J Neurochem 65:111-116
23. Heal DJ, Frankland ATJ, Buckett WR (1990) A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter DA metabolism in the brain. Neuropharmacology 29: 1141-1150
24. Imperato A, Angelucci L (1989) The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol Bull 25:383-389
25. Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35: 1503-1519
26. Li X-M, Perry KW, Fuller RW (1996) On the in vivo modulation of neostriatal DA release by fluoxetine and 5-HTP in conscious rats. J Pharm Pharmacol 48:825-828
27. 1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse 25:205-214
28. Meltzer HY (1991) The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17:263-286
29. Meltzer HY, Fibiger HC (1996) Olanzapine: a new atypical antipsychotic drug. Neuropsychopharmacology 14:83-85
30. Meltzer HY, Chai BL, Thompson PA, Yamamoto BK (1994) Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. J Pharmacol Exp Ther 268:1452-1461
31. Moghaddam B, Bunney BS (1990) Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 14:S51-S57
32. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine: a novel atypical antipsychotic agent. J Pharmacol Exp Ther 262:545-551
33. Moore NA, Rees G, Sanger G, Tye NC (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2:281-293
34. Moore NA, Rees G, Sanger G, Tye NC (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5:196-202
35. Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic DA neurons studied in vivo. Neurosci Lett 157:53-56
36. 2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology 16:1-7
37. 1 receptors in schizophrenia revealed by PET. Nature 385:634-636
38. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
39. Pehek EA, Yamamoto BY (1994) Differential effects of locally administered clozapine and haloperidol on DA efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63: 2118-2124
40. Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentrations in microdialysis fluid from rat striatum. Life Sci 50:1683-1690
41. Robertson GS, Fibiger HC (1996) Effects of olanzapine on regional c-Fos expression in rat forebrain. Neuropsychopharmacology 14:105-110
42. 1-dopamine receptors in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71:515-528
43. 2A receptor antagonist, MDL-100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 273:273-279
44. 4 receptors. Neuropsychopharmacology 16:93-110
45. Semba J, Sakai M, Miyoshi R, Mataga N, Fukamauchi F, Kito S (1996) Differential expression of c-Fos mRNA in rat prefrontal cortex, striatum, nucleus accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochem Int 29:435-442
46. Sesack SR, Pickel VM (1992) Prefrontal cortical efferent in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160
47. Stockton ME, Rasmussen K (1996) Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14:97-104
48. Tassin JP, Trovero F, Blanc G, Herve D, Glowinski J (1994) Interactions between NE and DA neurotransmission in the rat prefrontal cortex and their consequences on dopaminergic subcortical function. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson's disease. CRC Press, Boca Raton, Florida, pp 107-125
49. 1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16:104-112
50. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
51. Westerink BHC (1985) Sequence and significance of dopamine metabolism in the rat brain. Neurochem Int 7:221-227
52. Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York
53. Winn P (1994) Schizophrenia research moves to the prefrontal cortex. Trends Neural Sci 17:265-268
54. Wong DT, Bymaster EP, Engleman EA (1995) Presynaptic regulation of extracellular serotonin concentrations in brain. In: Takada A, Curzon G (eds) Serotonin in the central nervous system and periphery. Elsevier, New York, pp 3-13
55. Yamamoto BK, Pehek EA, Meltzer HY (1994) Brain region effects of clozapine on amino acid and monoamine transmission. J Clin Psychiatry 55 [Suppl B]:8-14
56. Zetterstrom T, Sharp T, Ungerstedt U (1985) Effect of neuroleptic drugs on striatal dopamine releases and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27-37